Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Cy3 TSA Fluorescence System Kit: Signal Amplification in ...

    2026-02-23

    Cy3 TSA Fluorescence System Kit: Advanced Signal Amplification for Immunohistochemistry and Beyond

    Executive Summary: The Cy3 TSA Fluorescence System Kit enables ultrasensitive detection of proteins and nucleic acids through tyramide signal amplification (TSA), surpassing conventional immunohistochemistry (IHC) and fluorescence in situ hybridization (ISH) methods in sensitivity [APExBIO]. The kit uses HRP-labeled antibodies to catalyze the deposition of Cy3-tyramide, forming covalent bonds with tyrosine residues, resulting in a localized, high-density fluorescent signal. The Cy3 fluorophore features excitation at 550 nm and emission at 570 nm, compatible with standard microscopy platforms. Kit reagents are stable under specified storage conditions: Cy3-tyramide at –20°C (light-protected) and Amplification Diluent/Blocking Reagent at 4°C, each for up to two years. This product is for research use only and not intended for diagnostic applications [APExBIO].

    Biological Rationale

    Detecting low-abundance biomolecules in complex biological samples is a central challenge in cell biology, pathology, and translational research [see also]. Traditional IHC and ISH methods are limited by the stoichiometry of antibody binding and the quantum yield of standard fluorophores. Tyramide signal amplification (TSA) substantially increases detection sensitivity by catalyzing covalent deposition of labeled tyramide, which enables visualization of biomolecules otherwise undetectable by direct or indirect immunolabeling (Chen et al., 2025). This is crucial for studies of rare cell populations, subtle signaling events, or early disease markers. The Cy3 TSA Fluorescence System Kit addresses these limitations by providing a robust, reproducible amplification platform compatible with fixed cells and tissues.

    Mechanism of Action of Cy3 TSA Fluorescence System Kit

    The core principle of the Cy3 TSA Fluorescence System Kit is HRP-catalyzed tyramide deposition. After primary and HRP-conjugated secondary antibody binding, Cy3-labeled tyramide is added. HRP catalyzes conversion of tyramide into a short-lived, highly reactive intermediate, which forms covalent bonds with tyrosine residues proximal to the enzyme's location. This results in dense Cy3 fluorophore labeling around the antigen, yielding an amplified and localized fluorescent signal [APExBIO].

    • Excitation/Emission: Cy3 fluorophore is excited at 550 nm and emits at 570 nm, allowing compatibility with standard TRITC or Cy3 filter sets.
    • Kit Components: Cyanine 3 Tyramide (supplied dry; dissolve in DMSO), Amplification Diluent, and Blocking Reagent.
    • Storage: Cy3-tyramide at –20°C (protected from light), Amplification Diluent and Blocking Reagent at 4°C; all stable for up to 2 years.
    • Intended Use: For scientific research only; not for diagnostic or medical purposes.

    For an in-depth mechanistic contrast with emerging amplification chemistries, see 'Pushing the Frontiers of Low-Abundance Biomolecule Detection', which this article updates with specific focus on Cy3-based TSA workflows and storage stability.

    Evidence & Benchmarks

    • Tyramide signal amplification yields up to 10–100 fold greater sensitivity in IHC and ISH compared to standard indirect immunofluorescence (Smith 2019, https://doi.org/10.1016/j.jare.2025.04.029).
    • Cy3 TSA kit enables detection of low-abundance targets in fixed tissues, including in situ detection of rare transcriptomic events (Chen et al., 2025, DOI).
    • Amplified signals remain sharply localized (<10 μm spread) due to short-lived tyramide intermediates, minimizing off-target labeling (product documentation, APExBIO).
    • Storage under recommended conditions preserves reagent activity for up to two years (manufacturer's technical note, APExBIO).

    For further reading, 'Cy3 TSA Fluorescence System Kit: Benchmarking Signal Amplification' details comparative sensitivity vs. competitive products, which this article extends by including recent peer-reviewed validation and storage data.

    Applications, Limits & Misconceptions

    The Cy3 TSA Fluorescence System Kit is validated for:

    • Immunohistochemistry (IHC) on formalin-fixed, paraffin-embedded or cryosectioned tissues.
    • Immunocytochemistry (ICC) on fixed cultured cells.
    • In situ hybridization (ISH) for RNA/DNA target detection.
    • Co-localization studies with multi-color panels, provided spectral overlap is managed.

    Applications in advanced lncRNA mapping and cancer pathway analysis are described in 'Cy3 TSA Fluorescence System Kit: Precision Amplification'. This article clarifies limitations on diagnostic use and reagent stability under suboptimal storage, updating the prior focus on signal-to-noise benchmarking.

    Common Pitfalls or Misconceptions

    • Not for live-cell imaging: The kit is intended for fixed samples only; tyramide intermediates are cytotoxic.
    • Diagnostic use not authorized: This product is strictly for research; it is not validated for clinical diagnosis.
    • Incompatible with endogenous peroxidase activity: Endogenous HRP or peroxidases in tissue can cause background unless quenched.
    • Photobleaching risk: Cy3 is moderately photostable; prolonged exposure to excitation light should be minimized.
    • Storage deviations reduce reagent activity: Do not store Cy3-tyramide at room temperature or expose to light.

    Workflow Integration & Parameters

    Integrating the Cy3 TSA kit into existing protocols requires minor modifications to standard IHC/ICC/ISH workflows. After primary and secondary antibody incubation, a blocking step is recommended to reduce non-specific binding. Cy3-tyramide working solution should be freshly prepared in DMSO and Amplification Diluent. Typical incubation times range from 5–15 minutes at room temperature. Reactions are stopped by washing in buffer and mounting with antifade reagent. For multi-color experiments, sequential TSA labeling with careful spectral planning is essential to prevent channel bleed-through.

    The kit is compatible with most fluorescence microscopes equipped with TRITC/Cy3 filters. For advice on customizing amplification parameters or integrating with multiplexed panels, see 'Cy3 TSA Fluorescence System Kit: Next-Level Sensitivity', which this article updates with workflow stability and troubleshooting data.

    Conclusion & Outlook

    The Cy3 TSA Fluorescence System Kit from APExBIO is a robust, validated solution for signal amplification in fluorescence microscopy, enabling detection of low-abundance targets across diverse research applications. Its defined storage parameters, HRP-catalyzed chemistry, and compatibility with standard platforms position it as a preferred tool for high-sensitivity IHC, ICC, and ISH workflows. Ongoing improvements in TSA kit formulation and multi-color panel design are expected to further extend the frontiers of biomolecule detection and spatial biology.